Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oncogene

Showing results (561-570 of 22,557) with videos related to

Pageof 2,256
Sort By:
Oncogene|July 20, 2007
Increased mitochondrial DNA induces acquired docetaxel resistance in head and neck cancer cellsT Mizumachi, S Suzuki, A Naito, et al.
Oncogene|July 20, 2007
Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stromaF Yang, D W Strand, D R Rowley
Oncogene|December 1, 1991
Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasiaJ Limpens, D de Jong, J H van Krieken, et al.
Oncogene|December 1, 1991
A 3' truncation of myc caused by chromosomal translocation in a human T-cell leukemia is tumorigenic when tested in established rat fibroblastsD F Aghib, J M Bishop
Oncogene|August 2, 2007
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myelomaC Scavelli, B Nico, T Cirulli, et al.
Oncogene|August 2, 2007
Targeting c-Jun and JunB proteins as potential anticancer cell therapyE N Gurzov, L Bakiri, J M Alfaro, et al.
Oncogene|August 2, 2007
Candidate tumor suppressor DDX3 RNA helicase specifically represses cap-dependent translation by acting as an eIF4E inhibitory proteinJ-W Shih, T-Y Tsai, C-H Chao, et al.
Oncogene|July 27, 2007
CEACAM5 and CEACAM6 are major target genes for Smad3-mediated TGF-beta signalingS-U Han, T-H Kwak, K H Her, et al.
Oncogene|July 27, 2007
EGFR mutants found in non-small cell lung cancer show different levels of sensitivity to suppression of Src: implications in targeting therapyY-N Fu, C-L Yeh, H H-Y Cheng, et al.
Oncogene|July 27, 2007
The steroid receptor coactivator-3 is a tumor promoter in a mouse model of thyroid cancerH Ying, M C Willingham, S-Y Cheng
Pageof 2,256

Showing results (561-570 of 22,557) with videos related to

Sort By:
Pageof 2,256
Oncogene|July 20, 2007
Increased mitochondrial DNA induces acquired docetaxel resistance in head and neck cancer cellsT Mizumachi, S Suzuki, A Naito, et al.
Oncogene|July 20, 2007
Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stromaF Yang, D W Strand, D R Rowley
Oncogene|December 1, 1991
Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasiaJ Limpens, D de Jong, J H van Krieken, et al.
Oncogene|December 1, 1991
A 3' truncation of myc caused by chromosomal translocation in a human T-cell leukemia is tumorigenic when tested in established rat fibroblastsD F Aghib, J M Bishop
Oncogene|August 2, 2007
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myelomaC Scavelli, B Nico, T Cirulli, et al.
Oncogene|August 2, 2007
Targeting c-Jun and JunB proteins as potential anticancer cell therapyE N Gurzov, L Bakiri, J M Alfaro, et al.
Oncogene|August 2, 2007
Candidate tumor suppressor DDX3 RNA helicase specifically represses cap-dependent translation by acting as an eIF4E inhibitory proteinJ-W Shih, T-Y Tsai, C-H Chao, et al.
Oncogene|July 27, 2007
CEACAM5 and CEACAM6 are major target genes for Smad3-mediated TGF-beta signalingS-U Han, T-H Kwak, K H Her, et al.
Oncogene|July 27, 2007
EGFR mutants found in non-small cell lung cancer show different levels of sensitivity to suppression of Src: implications in targeting therapyY-N Fu, C-L Yeh, H H-Y Cheng, et al.
Oncogene|July 27, 2007
The steroid receptor coactivator-3 is a tumor promoter in a mouse model of thyroid cancerH Ying, M C Willingham, S-Y Cheng
Pageof 2,256